Relative Impact of Pain and Disease Activity on Improvements in Fatigue: Results From 2 Baricitinib Phase 3 Clinical Trials

Fatigue is common in patients with rheumatoid arthritis (RA). We assessed the relative impact of pain and disease activity on improvements in fatigue in 2 phase 3 baricitinib clinical trials. METHODS: RA-BEAM (NCT01710358) and RA-BEACON (NCT01721044) were randomized, double-blind, placebo-controlled...

Descripción completa

Detalles Bibliográficos
Autores principales: Fautrel, Bruno, Wu, Jianmin, Wang, Duzhe, Haladyj, Ewa, van de Laar, Mart A. F. J., Takeuchi, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045960/
https://www.ncbi.nlm.nih.gov/pubmed/36473106
http://dx.doi.org/10.1097/RHU.0000000000001924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045960/
https://www.ncbi.nlm.nih.gov/pubmed/36473106
http://dx.doi.org/10.1097/RHU.0000000000001924

Ejemplares similares